Cleared Traditional

K213855 - Arrow Pressure Injectable Midline Catheter (FDA 510(k) Clearance)

Sep 2022
Decision
266d
Days
Class 2
Risk

K213855 is an FDA 510(k) clearance for the Arrow Pressure Injectable Midline Catheter. This device is classified as a Midline Catheter (Class II - Special Controls, product code PND).

Submitted by Arrow International, LLC Subsidiary of Teleflex Incorporated (Morrisville, US). The FDA issued a Cleared decision on September 2, 2022, 266 days after receiving the submission on December 10, 2021.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5200. The Catheter Is Inserted Into The Peripheral Vascular System For Infusion Of Fluids And Medications For Less Than 28 Days..

Submission Details

510(k) Number K213855 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 2021
Decision Date September 02, 2022
Days to Decision 266 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code PND - Midline Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5200
Definition The Catheter Is Inserted Into The Peripheral Vascular System For Infusion Of Fluids And Medications For Less Than 28 Days.